These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36082558)

  • 1. Biomaterials-based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents.
    Marshall GP; Cserny J; Wang CW; Looney B; Posgai AL; Bacher R; Keselowsky B; Brusko TM
    J Biomed Mater Res A; 2023 Feb; 111(2):185-197. PubMed ID: 36082558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
    Kornete M; Sgouroudis E; Piccirillo CA
    J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
    Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
    Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
    Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
    Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation Followed by Antigen-Specific T
    Cabello-Kindelan C; Mackey S; Sands A; Rodriguez J; Vazquez C; Pugliese A; Bayer AL
    Diabetes; 2020 Feb; 69(2):215-227. PubMed ID: 31712320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles.
    Neshat SY; Bauer SJ; Rhodes KR; Quiroz VM; Wong VW; Lowmaster SM; Tzeng SY; Green JJ; Doloff JC
    ACS Biomater Sci Eng; 2023 Jun; 9(6):3522-3534. PubMed ID: 37233985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.
    Xue M; Dervish S; Harrison LC; Fulcher G; Jackson CJ
    J Biol Chem; 2012 May; 287(20):16356-64. PubMed ID: 22447930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
    Li CR; Deiro MF; Godebu E; Bradley LM
    J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
    Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
    Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
    Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
    Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells.
    Shapiro MR; Peters LD; Brown ME; Cabello-Kindelan C; Posgai AL; Bayer AL; Brusko TM
    J Immunol; 2023 Oct; 211(7):1108-1122. PubMed ID: 37594278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.
    Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE
    Front Immunol; 2019; 10():2665. PubMed ID: 31824482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.
    Graham JG; Zhang X; Goodman A; Pothoven K; Houlihan J; Wang S; Gower RM; Luo X; Shea LD
    Tissue Eng Part A; 2013 Jun; 19(11-12):1465-75. PubMed ID: 23432371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
    Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
    Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.